Dalbavancin/daptomycin/vancomycinAcquired drug resistance

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2013卷 / 1期

关键词：

D O I：

10.1007/s40278-024-61166-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：152 / 152

相关论文

共 50 条

[1] Daptomycin/linezolid/vancomycinAcquired resistance: case report
Reactions Weekly, 2019, 1758 (1) : 131 - 131
[2] Ceftaroline fosamil/daptomycin/vancomycinAcquired resistance: case report
Reactions Weekly, 2021, 1853 (1) : 118 - 118
[3] Dalbavancin/daptomycin/oxacillinAntimicrobial resistance: case report
Reactions Weekly, 2019, 1760 (1) : 72 - 72
[4] VancomycinAcquired drug resistance: case report
Reactions Weekly, 2022, 1890 (1) : 249 - 249
[5] VancomycinAcquired drug resistance: case report
Reactions Weekly, 2024, 2036 (1) : 460 - 460
[6] VancomycinAcquired drug resistance: case report
Reactions Weekly, 2022, 1897 (1) : 347 - 347
[7] Daptomycin/Tigecycline/VancomycinAcquired bacterial resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2043 (1) : 129 - 129
[8] Mechanisms of drug resistance: daptomycin resistance
Tran, Truc T.
Munita, Jose M.
Arias, Cesar A.
ANTIMICROBIAL THERAPEUTICS REVIEWS, 2015, 1354 : 32 - 53
[9] Dalbavancin/vancomycinDevelopment of drug resistance: case report
Reactions Weekly, 2018, 1697 (1) : 135 - 135
[10] In vitro activity of daptomycin combined with dalbavancin and linezolid, and dalbavancin with linezolid against MRSA strains
Aktas, Gulseren
Derbentli, Sengul
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (02) : 441 - 443

← 1 2 3 4 5 →